BioCentury
ARTICLE | Management Tracks

Jones leaving BMS to become CMO of Cullinan

Plus Singleton to join Bioventus as CFO, and updates from Noema, Lycia, Avidity and more

March 1, 2022 12:29 AM UTC

Cullinan Oncology Inc. (NASDAQ:CGEM) hired Jeffrey Jones as CMO. Jones was most recently VP of global drug development, lymphoma and myeloid diseases at Bristol Myers Squibb Co. (NYSE:BMY). The company also said Anne-Marie Martin, SVP and global head of experimental medicine unit at GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), joined its board.

Mark Singleton will become SVP and CFO at Bioventus Inc. (NASDAQ:BVS) on March 21. Singleton joins from Teleflex Inc. (NYSE:TFX), where he was VP of finance, Americas. In November, the company announced that Greg Anglum, the current CFO, was leaving to pursue other career opportunities...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article